Commercialization Group Intended To Speed Time To Market, Merck Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Merck's new supply initiative includes creating a new commercialization organization that will operate under the manufacturing division, Manufacturing Division President Willie Deese said during a Nov. 28 conference call announcing Merck's restructuring plans
You may also be interested in...
Merck Begins Cuts With Manufacturing, More Cost Reductions To Follow
The company suggests future restructuring efforts could address R&D, marketing and sales after unveiling the first phase of its restructuring initiative.
Biohaven Shoots For Oral CGRP Leadership As Nurtec ODT Gains Momentum
The firm’s acute migraine treatment Nurtec ODT generated $65m in 2020 after launching a year ago. Biohaven aims for Nurtec to become the leader in what could be a $4bn-$5bn category in the US.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: